The present research work aims to formulate a cost-effective and less toxic drug for specific and selective delivery at the tumor site.
Background
Existing therapeutics, such as chemo, surgery, etc., for fast-paced MCF-7 breast cancer, still face challenges, especially due to their toxic side effects. The unique properties of metal nanoparticles embedded in anti-oxidant plant polymers have sparked great interest in the formulation of less toxic-targeted drugs for cancer cure.
Objective
The present work aims to synthesize a targeted formulation of colloidal nanosilver by surface engineering of silver nanoparticles using plant polymers in electrolytic deposition technique, developed indigenously at the institute lab.
Methods
A current is passed through an elctrolyte, AgNO3, which splits it into ions. The positive ions of Ag deposit over LDPE wrapped carbon cathode and negative ion, NO3, is liberated. Ag+ ions get capped in-situ. These surface-modified silver nanoparticles formulate a colloidal solution. UV-visible and FTIR spectroscopy, TEM-EDX, and XRD were used to validate as-prepared formulation and in vivo human tumor xenograft model in NOD-SCID mouse for efficacy against MCF-7 breast cancer.
Results
The as-synthesized formulation consists of pure spherical poly-dispersed silver nanoparticles of average size 5.4 nm, coated with sulphated flavanols. The efficacy evaluation reported that it significantly, T/C = 0.53, reduced tumor volumes with a 100% survival rate and change in animal body weight <4 gms.
Conclusion
The as-synthesized formulation can be used as a potential neo-adjuvant or adjuvant drug along with existing therapeutics for MCF-7 breast cancer, significantly reducing the toxicity and cost.
Bray
F.
Laversanne
M.
Sung
H.
Ferlay
J.
Siegel
R.L.
Soerjomataram
I.
Jemal
A.
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J. Clin.2024
74
3
229
263
10.3322/caac.21834
38572751
Elsori
D.
Pandey
P.
Ramniwas
S.
Kumar
R.
Lakhanpal
S.
Rab
S.O.
Siddiqui
S.
Singh
A.
Saeed
M.
Khan
F.
Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics.
Front. Pharmacol.2024
15
1406619
10.3389/fphar.2024.1406619
38957397
Peralta-Zaragoza
O.
Bermúdez-Morales
V.H.
Pérez-Plasencia
C.
Salazar-León
J.
Gómez-Cerón
C.
Madrid-Marina
V.
Targeted treatments for cervical cancer: a review.
OncoTargets Ther.2012
5
315
328
10.2147/OTT.S25123
23144564
Brahmer
J.R.
National Comprehensive Cancer Network. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
J. Clin. Oncol.2012
36
17
1714
1768
Bourke
P.
Ziuzina
D.
Han
L.
Cullen
P.J.
Gilmore
B.F.
Microbiological interactions with cold plasma.
J. Appl. Microbiol.2017
123
2
308
324
10.1111/jam.13429
28245092
Pandey
P.
Khan
F.
Qari
H.A.
Oves
M.
Rutin (Bioflavonoid) as Cell Signaling Pathway Modulator: Prospects in Treatment and Chemoprevention.
Pharmaceuticals (Basel)2021
14
11
1069
10.3390/ph14111069
34832851
Al Abboud
M.A.
Mashraqi
A.
Qanash
H.
Gattan
H.S.
Felemban
H.R.
Alkorbi
F.
Alawlaqi
M.M.
Abdelghany
T.M.
Moawad
H.
Green biosynthesis of bimetallic ZnO@AuNPs with its formulation into cellulose derivative: biological and environmental applications.
Bioresour. Bioprocess.2024
11
1
60
10.1186/s40643‑024‑00759‑3
38884830
Alghonaim
M.I.
Alsalamah
S.A.
Mohammad
A.M.
Green synthesis of bimetallic Se@TiO2NPs and their formulation into biopolymers and their utilization as antimicrobial, anti-diabetic, antioxidant, and healing agent in vitro.
Biomass Conv Bioref
202410.1007/s13399‑024‑05451‑2
Qanash
H.
Bazaid
A.
Aldarhami
A.
Alharbi
B.
Almashjary
M.
Hazzazi
M.
Felemban
H.
Abdelghany
T.
Phytochemical characterization and efficacy of Artemisia judaica extract loaded chitosan nanoparticles as inhibitors of cancer proliferation and microbial growth.
Polymers (Basel)2023
15
2
391
10.3390/polym15020391
36679271
Al-Rajhi
A.M.H.
Abdelghany
T.M.
Almuhayawi
M.S.
Alruhaili
M.H.
Al Jaouni
S.K.
Selim
S.
The green approach of chitosan/Fe2O3/ZnO-nanocomposite synthesis with an evaluation of its biological activities.
Applied Biological Chemistry2024
67
1
75
10.1186/s13765‑024‑00926‑2
Habeeb Rahuman
H.B.
Dhandapani
R.
Narayanan
S.
Palanivel
V.
Paramasivam
R.
Subbarayalu
R.
Thangavelu
S.
Muthupandian
S.
Medicinal plants mediated the green synthesis of silver nanoparticles and their biomedical applications.
IET Nanobiotechnol.2022
16
4
115
144
10.1049/nbt2.12078
35426251
Sharma
V.K.
Yngard
R.A.
Lin
Y.
Silver nanoparticles: Green synthesis and their antimicrobial activities.
Adv. Colloid Interface Sci.2009
145
1-2
83
96
10.1016/j.cis.2008.09.002
18945421
Abdelghany
T.M.
Al-Rajhi
A.M.H.
Al Abboud
M.A.
Alawlaqi
M.M.
Ganash Magdah
A.
Helmy
E.A.M.
Mabrouk
A.S.
Recent advances in green synthesis of silver nanoparticles and their applications: about future directions. A review.
Bionanoscience2018
8
1
5
16
10.1007/s12668‑017‑0413‑3
Khan
F.
Pandey
P.
Verma
M.
Ramniwas
S.
Lee
D.
Moon
S.
Park
M.N.
Upadhyay
T.K.
Kim
B.
Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy.
Biomed. Pharmacother.2024
173
116363
10.1016/j.biopha.2024.116363
38479184
Sadeghi
B.
Gholamhoseinpoor
F.
A study on the stability and green synthesis of silver nanoparticles using Ziziphora tenuior (Zt) extract at room temperature.
Spectrochim. Acta A Mol. Biomol. Spectrosc.2015
134
310
315
10.1016/j.saa.2014.06.046
25022503
Abd El-Ghany
T.M.
Stachybotrys chartarum: a novel biological agent for the extracellular synthesis of silver nanoparticles and their antimicrobial activity.
Indones. J. Biotechnol.2013
18
2
75
82
Dwivedi
A.D.
Gopal
K.
Biosynthesis of silver and gold nanoparticles using Chenopodium album leaf extract.
Colloids Surf. A Physicochem. Eng. Asp.2010
369
1-3
27
33
10.1016/j.colsurfa.2010.07.020
Santhoshkumar
T.
Rahuman
A.A.
Rajakumar
G.
Marimuthu
S.
Bagavan
A.
Jayaseelan
C.
Zahir
A.A.
Elango
G.
Kamaraj
C.
Synthesis of silver nanoparticles using Nelumbo nucifera leaf extract and its larvicidal activity against malaria and filariasis vectors.
Parasitol. Res.2011
108
3
693
702
10.1007/s00436‑010‑2115‑4
20978795
Ahmed
S.
Ahmad
M.
Swami
B.L.
Ikram
S.
A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: A green expertise.
J. Adv. Res.2016
7
1
17
28
10.1016/j.jare.2015.02.007
26843966
Iravani
S.
Korbekandi
H.
Mirmohammadi
S.V.
Zolfaghari
B.
Synthesis of silver nanoparticles: chemical, physical and biological methods.
Res. Pharm. Sci.2014
9
6
385
406
26339255
Vaidyanathan
R.
Kalishwaralal
K.
Gopalram
S.
Gurunathan
S.
RETRACTED: Nanosilver — The burgeoning therapeutic molecule and its green synthesis.
Biotechnol. Adv.2009
27
6
924
937
10.1016/j.biotechadv.2009.08.001
19686832
Pandey
P.
Ramniwas
S.
Verma
M.
Rautela
I.
Khan
F.
Shah
M.A.
A comprehensive review uncovering the anticancerous potential of genkwanin (plant-derived compound) in several human carcinomas.
Open Chem.2024
22
1
20240003
10.1515/chem‑2024‑0003
Kikuchi
H.
Yuan
B.
Hu
X.
Okazaki
M.
Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents.
Am. J. Cancer Res.2019
9
8
1517
1535
31497340
Khan
A.U.
Dagur
H.S.
Khan
M.
Malik
N.
Alam
M.
Mushtaque
M.
Therapeutic role of flavonoids and flavones in cancer prevention: Current trends and future perspectives.
European Journal of Medicinal Chemistry Reports2021
3
100010
10.1016/j.ejmcr.2021.100010
Mir
S.A.
Dar
A.
Hamid
L.
Nisar
N.
Malik
J.A.
Ali
T.
Bader
G.N.
Flavonoids as promising molecules in the cancer therapy: An insight.
Current Research in Pharmacology and Drug Discovery2024
6
100167
10.1016/j.crphar.2023.100167
38144883
Asnaashari
S.
Amjad
E.
Sokouti
B.
Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review.
Cancer Cell Int.2023
23
1
211
10.1186/s12935‑023‑03052‑z
37743502
Pandey
P.
Khan
F.
Ramniwas
S.
Saeed
M.
Ahmad
I.
A mechanistic review of the pharmacological potential of narirutin: a dietary flavonoid.
Naunyn Schmiedebergs Arch. Pharmacol.2024
397
8
5449
5461
10.1007/s00210‑024‑03022‑w
38457040
Sysak
S.
Czarczynska-Goslinska
B.
Szyk
P.
Koczorowski
T.
Mlynarczyk
D.T.
Szczolko
W.
Lesyk
R.
Goslinski
T.
Metal Nanoparticle-Flavonoid Connections: Synthesis, Physicochemical and Biological Properties, as Well as Potential Applications in Medicine.
Nanomaterials (Basel)2023
13
9
1531
10.3390/nano13091531
37177076
Li
Z.
Le
W.
Cui
Z.
A novel therapeutic anticancer property of raw garlic extract via injection but not ingestion.
Cell Death Discov.2018
4
1
108
10.1038/s41420‑018‑0122‑x
Wang
H.
Li
X.
Liu
X.
Shen
D.
Qiu
Y.
Zhang
X.
Song
J.
Influence of PH, concentration and light on stability of allicin in garlic (Allium sativum L.) aqueous extract as measured by UPLC.
J. Sci. Food Agric.2015
95
9
1838
1844
10.1002/jsfa.6884
25205359
Rajawat
S.
Qureshi
M.S.
Electrolytic Deposition of Silver Nanoparticles Under “Principles of Green Chemistry”.
Arab. J. Sci. Eng.2014
39
1
563
568
10.1007/s13369‑013‑0879‑4
Shweta
R.
Rajnish
K.
Rajukumar
K.
Shreyas
P.
Sonali
S.
Qureshi
M.S.
Study of anti-cancer properties of green silver nanoparticles against MCF-7 breast cancer cell lines.
Green Process Synth2016
5
173
181
Chandran
S.P.
Chaudhary
M.
Pasricha
R.
Ahmad
A.
Sastry
M.
Synthesis of gold nanotriangles and silver nanoparticles using Aloe vera plant extract.
Biotechnol. Prog.2006
22
2
577
583
10.1021/bp0501423
16599579
El-Kheshen
A.A.
El-Rab
S.F.G.
Effect of reducing and protecting agents on size of silver nanoparticles and their anti-bacterial activity Pharm.
Chem2012
4
1
53
65
Jiang, 2011, X. C. Jiang, W. M. Chen, C. Y. Chen, S.X. Xiong, A.B. Yu Role of temperature in the growth of silver nanoparticles through a synergetic reduction approach.
Nanoscale Res. Lett.2011
6
3
Kim
D.
Jeong
S.
Moon
J.
Synthesis of silver nanoparticles using the polyol process and the influence of precursor injection.
Nanotechnology2006
17
16
4019
4024
10.1088/0957‑4484/17/16/004
21727531
Shervani
Z.
Ikushima
Y.
Sato
M.
Kawanami
H.
Hakuta
Y.
Yokoyama
T.
Nagase
T.
Kuneida
H.
Aramaki
K.
Morphology and size-controlled synthesis of silver nanoparticles in aqueous surfactant polymer solutions.
Colloid Polym. Sci.2008
286
4
403
410
10.1007/s00396‑007‑1784‑8
Ciapina
E.G.
dos Santos
M.L.
Santos
R.M.I.S.
Palombarini
J.
Almeida Júnior
O.P.
Santana
J.C.C.C.
Modesto
D.A.
Lanfredi
A.J.C.
Santos
S.F.
On the lattice dilation of palladium nanoparticles and a new methodology for the quantification of interstitials.
J. Alloys Compd.2021
881
160628
10.1016/j.jallcom.2021.160628
Wasserman
H.J.
Vermaak
J.S.
On the determination of a lattice contraction in very small silver particles.
Surf. Sci.1970
22
1
164
172
10.1016/0039‑6028(70)90031‑2
Prakash
P.
Gnanaprakasam
P.
Emmanuel
R.
Arokiyaraj
S.
Saravanan
M.
Green synthesis of silver nanoparticles from leaf extract of Mimusops elengi, Linn. for enhanced antibacterial activity against multi drug resistant clinical isolates.
Colloids Surf. B Biointerfaces2013
108
255
259
10.1016/j.colsurfb.2013.03.017
23563291
Niraimathi
K.L.
Sudha
V.
Lavanya
R.
Brindha
P.
Biosynthesis of silver nanoparticles using Alternanthera sessilis (Linn.) extract and their antimicrobial, antioxidant activities.
Colloids Surf. B Biointerfaces2013
102
288
291
10.1016/j.colsurfb.2012.08.041
23006568
Restrepo
C.V.
Villa
C.C.
Synthesis of silver nanoparticles, influence of capping agents, and dependence on size and shape: A review.
Environ. Nanotechnol. Monit. Manag.2021
15
100428
10.1016/j.enmm.2021.100428
Sidhu
A.K.
Verma
N.
Kaushal
P.
Role of Biogenic Capping Agents in the Synthesis of Metallic Nanoparticles and Evaluation of Their Therapeutic Potential.
Frontiers in Nanotechnology2022
3
801620
10.3389/fnano.2021.801620
Guilger-Casagrande
M.
Germano-Costa
T.
Bilesky-José
N.
Pasquoto-Stigliani
T.
Carvalho
L.
Fraceto
L.F.
de Lima
R.
Influence of the capping of biogenic silver nanoparticles on their toxicity and mechanism of action towards Sclerotinia sclerotiorum.
J. Nanobiotechnology2021
19
1
53
10.1186/s12951‑021‑00797‑5
33627148
Hasan
K.M.F.
Xiaoyi
L.
Shaoqin
Z.
Horváth
P.G.
Bak
M.
Bejó
L.
Sipos
G.
Alpár
T.
Functional silver nanoparticles synthesis from sustainable point of view: 2000 to 2023 ‒ A review on game changing materials.
Heliyon2022
8
12
e12322
10.1016/j.heliyon.2022.e12322
36590481
Shume
W.M.
Murthy
H.C.A.
Zereffa
E.A.
A Review on Synthesis and Characterization of Ag 2 O Nanoparticles for Photocatalytic Applications.
J. Chem.2020
2020
1
15
10.1155/2020/5039479
Al-Zahrani
S.
Astudillo-Calderón
S.
Pintos
B.
Pérez-Urria
E.
Manzanera
J.A.
Martín
L.
Gomez-Garay
A.
Role of Synthetic Plant Extracts on the Production of Silver-Derived Nanoparticles.
Plants2021
10
8
1671
10.3390/plants10081671
34451715
Zaheer
Z.
Rafiuddin, Silver nanoparticles to self-assembled films: Green synthesis and characterization.
Colloids Surf. B Biointerfaces2012
90
48
52
10.1016/j.colsurfb.2011.09.037
22055624
Hema
J.A.
Malaka
R.
Muthukumarasamy
N.P.
Sambandam
A.
Subramanian
S.
Sevanan
M.
Green synthesis of silver nanoparticles using Zea mays and exploration of its biological applications.
IET Nanobiotechnol.2016
10
5
288
294
10.1049/iet‑nbt.2015.0103
27676376
Siddiqi
K.S.
Husen
A.
Rao
R.A.K.
A review on biosynthesis of silver nanoparticles and their biocidal properties.
J. Nanobiotechnology2018
16
1
14
10.1186/s12951‑018‑0334‑5
29452593
Ibrahim
N.H.
Taha
G.M.
Hagaggi
N.S.A.
Moghazy
M.A.
Green synthesis of silver nanoparticles and its environmental sensor ability to some heavy metals.
BMC Chem.2024
18
1
7
10.1186/s13065‑023‑01105‑y
38184656
Brede
C.
Labhasetwar
V.
Applications of nanoparticles in the detection and treatment of kidney diseases.
Adv. Chronic Kidney Dis.2013
20
6
454
465
10.1053/j.ackd.2013.07.006
24206598
Ma
Y.
Cai
F.
Li
Y.
Chen
J.
Han
F.
Lin
W.
A review of the application of nanoparticles in the diagnosis and treatment of chronic kidney disease.
Bioact. Mater.2020
5
3
732
743
10.1016/j.bioactmat.2020.05.002
32596555
Trac
N.
Ashraf
A.
Giblin
J.
Prakash
S.
Mitragotri
S.
Chung
E.J.
Spotlight on Genetic Kidney Diseases: A Call for Drug Delivery and Nanomedicine Solutions.
ACS Nano2023
17
7
6165
6177
10.1021/acsnano.2c12140
36988207
Yang
K.
Shang
Y.
Yang
N.
Pan
S.
Jin
J.
He
Q.
Application of nanoparticles in the diagnosis and treatment of chronic kidney disease.
Front. Med. (Lausanne)2023
10
1132355
10.3389/fmed.2023.1132355
37138743
Workman
P.
Aboagye
E.O.
Balkwill
F.
Balmain
A.
Bruder
G.
Chaplin
D.J.
Double
J.A.
Everitt
J.
Farningham
D A H.
Glennie
M.J.
Kelland
L.R.
Robinson
V.
Stratford
I.J.
Tozer
G.M.
Watson
S.
Wedge
S.R.
Eccles
S.A.
Guidelines for the welfare and use of animals in cancer research.
Br. J. Cancer2010
102
11
1555
1577
10.1038/sj.bjc.6605642
20502460
Martin
E.C.
Aarons
L.
Yates
J.W.T.
Accounting for dropout in xenografted tumour efficacy studies: integrated endpoint analysis, reduced bias and better use of animals.
Cancer Chemother. Pharmacol.2016
78
1
131
141
10.1007/s00280‑016‑3059‑x
27220867
Chen
H.
Ye
Q.
Lv
J.
Ye
P.
Sun
Y.
Fan
S.
Su
X.
Gavine
P.
Yin
X.
Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models.
Pathol. Oncol. Res.2015
21
4
947
955
10.1007/s12253‑015‑9909‑8
25749810
Tsukihara
H.
Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts.
Oncol. Rep.2015
33
5
2135
2142
10.3892/or.2015.3876